Signaling in Rodent Dilated Ischemic Cardiomyopathy-Adrenoreceptor Subtype β Beneficial Effects of Chronic Pharmacological Manipulation of

Ismayil Ahmet, Melissa Krawczyk, Phillip Heller, Chanil Moon, Edward G. Lakatta and Mark I. Signaling in Rodent Dilated Ischemic Cardiomyopathy -Adrenoreceptor Subtype β Beneficial Effects of Chronic Pharmacological Manipulation of Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2004 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000139844.15045.F9 2004;110:1083-1090; originally published online August 16, 2004; Circulation. http://circ.ahajournals.org/content/110/9/1083 World Wide Web at: The online version of this article, along with updated information and services, is located on the http://circ.ahajournals.org/content/suppl/2004/08/30/01.CIR.0000139844.15045.F9.DC1.html Data Supplement (unedited) at:

[1]  E. Lakatta,et al.  Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. , 2004, American journal of physiology. Heart and circulatory physiology.

[2]  T. Reffelmann,et al.  Cardioprotection by Carvedilol: Antiapoptosis is Independent of β-Adrenoceptor Blockage in the Rat Heart , 2003, Journal of cardiovascular pharmacology and therapeutics.

[3]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[4]  R. Kitsis,et al.  A mechanistic role for cardiac myocyte apoptosis in heart failure. , 2003, The Journal of clinical investigation.

[5]  S. Vatner,et al.  Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. , 2003, The Journal of clinical investigation.

[6]  B. Kobilka,et al.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.

[7]  R. Seifert,et al.  Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. , 2002, Biochemical pharmacology.

[8]  B. Kobilka,et al.  Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Lakatta,et al.  The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase , 2000 .

[10]  John Wikstrand,et al.  Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .

[11]  P. Hildebrandt,et al.  Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. , 2000, Journal of the American College of Cardiology.

[12]  J. Sanderson,et al.  Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. , 2000, Journal of the American College of Cardiology.

[13]  F. Eberli,et al.  Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. , 2000, American journal of physiology. Heart and circulatory physiology.

[14]  G. Dorn,et al.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.

[15]  Catherine Communal,et al.  Opposing Effects of β1- and β2-Adrenergic Receptors on Cardiac Myocyte Apoptosis Role of a Pertussis Toxin–Sensitive G Protein , 1999 .

[16]  R. Watson,et al.  Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. , 1999, American journal of physiology. Heart and circulatory physiology.

[17]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Luchner,et al.  Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits. , 1999, Journal of cardiac failure.

[19]  E. Lakatta,et al.  beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. , 1999, Circulation.

[20]  E. Lakatta,et al.  Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes. , 1999, Circulation research.

[21]  A. Borczuk,et al.  β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.

[22]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[23]  E. Lakatta,et al.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. , 1995, Molecular pharmacology.

[24]  J S Hochman,et al.  Expansion of acute myocardial infarction: an experimental study. , 1982, Circulation.